Accuray ( NASDAQ:ARAY – Get Free Report ) last released its quarterly earnings results on Wednesday, August 13th. The medical equipment provider reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.03 by ($0.02). The firm had revenue of $127.54 million for the quarter, compared to analysts' expectations of $123.78 million. Accuray had a negative net margin of 0.35% and a negative return on equity of 4.92%. Accuray has set its FY 2026 guidance at EPS. As a group, analysts anticipate that Accuray will post 0.01 earnings per share for the current year.